Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FYAW4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,742
Award facts
- Contract value 100% obligated
- $33,741.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,741.79 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulations. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of May 13, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
Cosentyx is a biologic medication used for the treatment of various autoimmune and inflammatory conditions, including psoriasis, psoriatic arthritis, and ankylosing spondylitis. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a wide range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order demonstrates the company's ongoing capacity to fulfill federal medical supply requirements for specialty pharmaceutical products supporting military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FYAW4?
SPE2DB25FYAW4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 12, 2025.
How much is contract SPE2DB25FYAW4 worth?
The government has obligated $33,742 on SPE2DB25FYAW4.
Is contract SPE2DB25FYAW4 an order under another contract?
Yes. SPE2DB25FYAW4 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYAW4 competed?
The extent of competition for SPE2DB25FYAW4 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award